Pricing Log in Create free account
Friday 6 November 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025.

Revenue
+1.33%
EPS
+418.2%
Free cash flow
−6.83%
Total debt
−42.2%

Quarter to June 2026, against a year earlier

72.78 0.12 +0.17%
Market cap
$11.4B
P/E
62.2×
Fwd P/E
54.2×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Bio-Techne Corp (TECH) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 3, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-K/A Jun 30, 2026 An amendment; amendments are not compared
8-K Sep 23, 2026 5.07 Submission of matters to a vote of security holders; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Sep 14, 2026 8.01 Other events
10-K Jun 30, 2026 1: 3 added · 3 removed · 37 modified
1A: 28 added · 2 removed · 31 modified
7: 16 added · 18 removed · 50 modified
8-K Aug 12, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Jun 23, 2026 1.01 Entry into a material definitive agreement; 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
8-K Jun 25, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 11 modified
P2I1A: no material changes, the filing says
8-K May 6, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 9, 2026 5.02 Departure or appointment of directors or officers; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Dec 31, 2025
8-K Feb 4, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 8 added · 15 removed · 26 modified
P2I1A: no material changes, the filing says
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 5.07 Submission of matters to a vote of security holders; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Jun 30, 2025 1: 40 modified
1A: 1 added · 1 removed · 8 modified
7: 15 added · 22 removed · 35 modified
8-K Aug 6, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025 P1I2: 1 added · 1 removed · 22 modified
P2I1A: no comparison — the earlier filing's Item cannot be compared
8-K May 7, 2025 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Dec 31, 2024 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no material changes, the filing says
8-K Jan 30, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 25, 2024 2.02 Results of operations and financial condition; 5.07 Submission of matters to a vote of security holders; 8.01 Other events; 9.01 Financial statements and exhibits
10-K Jun 30, 2024
8-K Aug 7, 2024 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 1, 2024 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
8-K Feb 1, 2024 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.